HLA polymorphisms are associated with treatment-free remission following discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia.
Ureshino, Hiroshi, Shindo, Takero, Tanaka, Hidenori, Saji, Hiroh, Kimura, ShinyaJournal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-20-0336
Date:
October, 2020
File:
PDF, 2.23 MB
2020